ペプチドリームの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/10/06 | 3,570 | 3,575 | 3,470 | 3,500 | -65 | -1.8% | 715,900 |
| 2017/10/05 | 3,570 | 3,615 | 3,540 | 3,565 | +25 | +0.7% | 922,400 |
| 2017/10/04 | 3,515 | 3,565 | 3,475 | 3,540 | +25 | +0.7% | 736,300 |
| 2017/10/03 | 3,490 | 3,530 | 3,475 | 3,515 | +40 | +1.2% | 679,200 |
| 2017/10/02 | 3,470 | 3,505 | 3,445 | 3,475 | +5 | +0.1% | 744,400 |
| 2017/09/29 | 3,400 | 3,480 | 3,385 | 3,470 | +90 | +2.7% | 728,000 |
| 2017/09/28 | 3,390 | 3,390 | 3,325 | 3,380 | +15 | +0.4% | 891,500 |
| 2017/09/27 | 3,430 | 3,440 | 3,345 | 3,365 | -70 | -2% | 980,700 |
| 2017/09/26 | 3,435 | 3,465 | 3,420 | 3,435 | -25 | -0.7% | 726,900 |
| 2017/09/25 | 3,500 | 3,530 | 3,415 | 3,460 | -20 | -0.6% | 998,600 |
| 2017/09/22 | 3,480 | 3,520 | 3,445 | 3,480 | ±0 | ±0% | 852,600 |
| 2017/09/21 | 3,465 | 3,500 | 3,455 | 3,480 | +10 | +0.3% | 714,100 |
| 2017/09/20 | 3,495 | 3,570 | 3,445 | 3,470 | -55 | -1.6% | 1,214,300 |
| 2017/09/19 | 3,550 | 3,550 | 3,495 | 3,525 | ±0 | ±0% | 857,200 |
| 2017/09/15 | 3,520 | 3,575 | 3,495 | 3,525 | -20 | -0.6% | 750,300 |
| 2017/09/14 | 3,540 | 3,600 | 3,530 | 3,545 | +5 | +0.1% | 666,600 |
| 2017/09/13 | 3,640 | 3,650 | 3,525 | 3,540 | -75 | -2.1% | 1,036,800 |
| 2017/09/12 | 3,610 | 3,635 | 3,570 | 3,615 | +45 | +1.3% | 838,300 |
| 2017/09/11 | 3,525 | 3,625 | 3,500 | 3,570 | +110 | +3.2% | 1,157,100 |
| 2017/09/08 | 3,450 | 3,505 | 3,440 | 3,460 | -30 | -0.9% | 1,055,300 |
| 2017/09/07 | 3,665 | 3,675 | 3,480 | 3,490 | -185 | -5% | 1,811,700 |
| 2017/09/06 | 3,475 | 3,695 | 3,475 | 3,675 | +85 | +2.4% | 1,333,200 |
| 2017/09/05 | 3,705 | 3,755 | 3,580 | 3,590 | -130 | -3.5% | 1,626,000 |
| 2017/09/04 | 3,840 | 3,840 | 3,685 | 3,720 | -135 | -3.5% | 1,328,500 |
| 2017/09/01 | 3,890 | 3,915 | 3,820 | 3,855 | +20 | +0.5% | 1,454,500 |
| 2017/08/31 | 3,780 | 3,840 | 3,765 | 3,835 | +75 | +2% | 1,207,200 |
| 2017/08/30 | 3,830 | 3,870 | 3,750 | 3,760 | -15 | -0.4% | 1,779,600 |
| 2017/08/29 | 3,705 | 3,795 | 3,685 | 3,775 | +10 | +0.3% | 1,671,800 |
| 2017/08/28 | 3,790 | 3,880 | 3,730 | 3,765 | +60 | +1.6% | 2,354,800 |
| 2017/08/25 | 3,560 | 3,710 | 3,560 | 3,705 | +145 | +4.1% | 2,778,000 |
| 2017/08/24 | 3,535 | 3,625 | 3,535 | 3,560 | -35 | -1% | 2,391,400 |
| 2017/08/23 | 3,515 | 3,610 | 3,475 | 3,595 | +105 | +3% | 1,821,600 |
| 2017/08/22 | 3,480 | 3,520 | 3,460 | 3,490 | +15 | +0.4% | 596,200 |
| 2017/08/21 | 3,500 | 3,530 | 3,455 | 3,475 | -25 | -0.7% | 627,200 |
| 2017/08/18 | 3,450 | 3,520 | 3,435 | 3,500 | -5 | -0.1% | 576,200 |
| 2017/08/17 | 3,515 | 3,540 | 3,485 | 3,505 | +15 | +0.4% | 750,400 |
| 2017/08/16 | 3,415 | 3,495 | 3,395 | 3,490 | +55 | +1.6% | 685,900 |
| 2017/08/15 | 3,380 | 3,450 | 3,350 | 3,435 | +25 | +0.7% | 818,300 |
| 2017/08/14 | 3,225 | 3,440 | 3,200 | 3,410 | +115 | +3.5% | 1,445,500 |
| 2017/08/10 | 3,315 | 3,345 | 3,200 | 3,295 | -90 | -2.7% | 1,719,500 |
| 2017/08/09 | 3,435 | 3,435 | 3,320 | 3,385 | -80 | -2.3% | 757,400 |
| 2017/08/08 | 3,485 | 3,530 | 3,465 | 3,465 | +10 | +0.3% | 872,900 |
| 2017/08/07 | 3,475 | 3,475 | 3,420 | 3,455 | +45 | +1.3% | 488,900 |
| 2017/08/04 | 3,345 | 3,420 | 3,330 | 3,410 | +60 | +1.8% | 413,700 |
| 2017/08/03 | 3,355 | 3,360 | 3,295 | 3,350 | +15 | +0.4% | 523,000 |
| 2017/08/02 | 3,360 | 3,380 | 3,330 | 3,335 | -25 | -0.7% | 503,500 |
| 2017/08/01 | 3,455 | 3,460 | 3,335 | 3,360 | -110 | -3.2% | 943,400 |
| 2017/07/31 | 3,520 | 3,520 | 3,465 | 3,470 | -50 | -1.4% | 582,900 |
| 2017/07/28 | 3,510 | 3,535 | 3,480 | 3,520 | -40 | -1.1% | 658,000 |
| 2017/07/27 | 3,500 | 3,585 | 3,490 | 3,560 | +80 | +2.3% | 1,246,400 |
1851～
1900
件表示中 / 2911件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ペプチド | 184,600円 | +5.0% | +1.5% | 0.00% | 15.85倍 | 4.22倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 住友ファーマ | 91,400円 | +26.8% | - | 0.00% | 15.39倍 | 3.18倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 368,800円 | +20.9% | +87.3% | 3.69% | 8.24倍 | 0.95倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 328,400円 | +8.0% | -15.3% | 3.78% | 9.22倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 197,000円 | +4.0% | +25.4% | 2.69% | 8.62倍 | 1.13倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム
